The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo

被引:214
作者
Liu, Y
Snow, BE
Hande, MP
Yeung, D
Erdmann, NJ
Wakeham, A
Itie, A
Siderovski, DP
Lansdorp, PM
Robinson, MO
Harrington, L
机构
[1] Univ Toronto, Dept Med Biophys, Ontario Canc Inst, Amgen Inst, Toronto, ON M5G 2C1, Canada
[2] Columbia Univ, Coll Phys & Surg, Ctr Radiol Res, New York, NY 10032 USA
[3] Amgen Corp, Thousand Oaks, CA 91320 USA
[4] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA
[5] British Columbia Canc Res Ctr, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada
[6] Univ British Columbia, Dept Med, Vancouver, BC V6T 1Z3, Canada
关键词
D O I
10.1016/S0960-9822(00)00805-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mammalian telomerase is essential for the maintenance of telomere length [1-5]. Its catalytic core comprises a reverse transcriptase component (TERT) and an RNA component. While the biochemical role of mammalian TERT is well established [6-11], it is unknown whether it is sufficient for telomere-length maintenance, chromosome stability or other cellular processes. Cells from mice in which the mTert gene had been disrupted showed progressive loss of telomere DNA, a phenotype similar to cells in which the gene encoding the telomerase RNA component (mTR) has been disrupted [1,12]. On prolonged growth, mTert-deficient embryonic stem (ES) cells exhibited genomic instability, aneuploidy and telomeric fusions. ES cells heterozygous for the mTert disruption also showed telomere attrition, a phenotype that differs from heterozygous mTR cells [12]. Thus, telomere maintenance in mammals is carried out by a single, limiting TERT.
引用
收藏
页码:1459 / 1462
页数:4
相关论文
共 27 条
[1]   Reconstitution of human telomerase activity in vitro [J].
Beattie, TL ;
Zhou, W ;
Robinson, MO ;
Harrington, L .
CURRENT BIOLOGY, 1998, 8 (03) :177-180
[2]   Telomere shortening and tumor formation by mouse cells lacking telomerase RNA [J].
Blasco, MA ;
Lee, HW ;
Hande, MP ;
Samper, E ;
Lansdorp, PM ;
DePinho, RA ;
Greider, CW .
CELL, 1997, 91 (01) :25-34
[3]   Extension of life-span by introduction of telomerase into normal human cells [J].
Bodnar, AG ;
Ouellette, M ;
Frolkis, M ;
Holt, SE ;
Chiu, CP ;
Morin, GB ;
Harley, CB ;
Shay, JW ;
Lichtsteiner, S ;
Wright, WE .
SCIENCE, 1998, 279 (5349) :349-352
[4]   Disruption of the telomerase catalytic subunit gene from Arabidopsis inactivates telomerase and leads to a slow loss of telomeric DNA [J].
Fitzgerald, MS ;
Riha, K ;
Gao, F ;
Ren, SX ;
McKnight, TD ;
Shippen, DE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) :14813-14818
[5]   IDENTIFICATION OF A SPECIFIC TELOMERE TERMINAL TRANSFERASE-ACTIVITY IN TETRAHYMENA EXTRACTS [J].
GREIDER, CW ;
BLACKBURN, EH .
CELL, 1985, 43 (02) :405-413
[6]   Inhibition of telomerase limits the growth of human cancer cells [J].
Hahn, WC ;
Stewart, SA ;
Brooks, MW ;
York, SG ;
Eaton, E ;
Kurachi, A ;
Beijersbergen, RL ;
Knoll, JHM ;
Meyerson, M ;
Weinberg, RA .
NATURE MEDICINE, 1999, 5 (10) :1164-1170
[7]   Human telomerase contains evolutionarily conserved catalytic and structural subunits [J].
Harrington, L ;
Zhou, W ;
McPhail, T ;
Oulton, R ;
Yeung, DSK ;
Mar, V ;
Bass, MB ;
Robinson, MO .
GENES & DEVELOPMENT, 1997, 11 (23) :3109-3115
[8]   Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death [J].
Herbert, BS ;
Pitts, AE ;
Baker, SI ;
Hamilton, SE ;
Wright, WE ;
Shay, JW ;
Corey, DR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (25) :14276-14281
[9]   Disease states associated with telomerase deficiency appear earlier in mice with short telomeres [J].
Herrera, E ;
Samper, E ;
Martin-Caballero, J ;
Flores, JM ;
Lee, HW ;
Blasco, MA .
EMBO JOURNAL, 1999, 18 (11) :2950-2960
[10]   Telomere shortening in mTR-/- embryos is associated with failure to close the neural tube [J].
Herrera, E ;
Samper, E ;
Blasco, MA .
EMBO JOURNAL, 1999, 18 (05) :1172-1181